Clinical Trials Logo
  1. Home
  2. Conjunctivitis
  3. NCT01028027

Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

Blepharitis Clinical Trial

Official title:
A Clinical Safety and Efficacy Evaluation of Zylet® Versus Tobradex in the Treatment of Blepharokeratoconjunctivitis

Clinical Trial Summary

This study is to evaluate the safety and efficacy of loteprednol etabonate [LE] and tobramycin ophthalmic suspension versus tobramycin and dexamethasone ophthalmic suspension in the treatment of ocular inflammation associated with blepharokeratoconjunctivitis (BKC).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01028027
Study type Interventional
Source Bausch & Lomb Incorporated
Contact
Status Completed
Phase Phase 3
Start date October 2009
Completion date March 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT04475432 - Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis Phase 2/Phase 3
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT05629390 - Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study Phase 3
Terminated NCT02938078 - Ocular Comfort and Inflammation in Lid Hygiene Therapy N/A
Completed NCT01408082 - Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Phase 3
Recruiting NCT04858113 - Short-term Effects on Tear Film (Baby Shampoo vs Blephasol) N/A
Completed NCT00560703 - Treatment of Patients With Blepharitis and Facial Rosacea Phase 2
Recruiting NCT02455895 - Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora N/A
Completed NCT00894530 - The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) Phase 2
Completed NCT01115192 - Blephacura Versus Baby Shampoo to Treat Blepharitis N/A
Completed NCT02386774 - Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa N/A
Completed NCT01808560 - Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery N/A
Completed NCT01089608 - Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Phase 2
Completed NCT00629590 - Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis Phase 4
Completed NCT00629941 - Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis Phase 4
Completed NCT03926026 - Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis Phase 2
Recruiting NCT04603222 - Evaluation of SUMMIT BRUSH in Treatment of Blepharitis N/A
Completed NCT02218489 - Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Phase 2
Completed NCT00796926 - Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes Phase 3
Completed NCT00803452 - Lipids of the Human Tear Film and Their Effect on Tear Stability Phase 4